Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 03, 2015 1:46 PM ET

Capital Markets

Company Overview of Novartis Venture Fund

Company Overview

Novartis Venture Fund is an evergreen fund. It is stage agnostic but specializes in investment in seed, early stage, and later stage investments but can also invest in other stages. It focuses on Series A and B for initial investment. The fund prefers to invest in product-and platform-focused biotech, pharmaceutical, medical devices and diagnostics, and healthcare sectors. The fund primarily invests in companies based in the United States and Europe. As the initial or follow-on investments, it typically invests between $10 million and $20 million. It typically takes a 25 percent (app) stake in its portfolio companies along with taking a board seat. It can also make follow on investments depe...

Postfach

Basel,  4002

Switzerland

Founded in 1996

Phone:

41 61 324 32 67

Fax:

41 61 324 86 79

Key Executives for Novartis Venture Fund

Managing Director
Age: 37
Managing Director
Compensation as of Fiscal Year 2014.

Novartis Venture Fund Key Developments

Novartis Venture Fund Presents at BIO-Europe Spring 2015, Mar-09-2015 04:00 PM

Novartis Venture Fund Presents at BIO-Europe Spring 2015, Mar-09-2015 04:00 PM. Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France. Speakers: Anja König, Managing Director.

Novartis Venture Fund Presents at 8th Annual EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION, Mar-03-2015 11:30 AM

Novartis Venture Fund Presents at 8th Annual EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION, Mar-03-2015 11:30 AM. Venue: Hilton, Zurich Airport Hotel, Hohenbuehlstrasse 10, Opfikon-Glattbrugg 8152 Zurich, Zurich, Switzerland. Speakers: Anja König, Managing Director.

Novartis Venture Fund Presents at 14th Annual Biotech in Europe Forum for Global Partnering & Investment, Sep-30-2014 through Oct-01-2014

Novartis Venture Fund Presents at 14th Annual Biotech in Europe Forum for Global Partnering & Investment, Sep-30-2014 through Oct-01-2014. Venue: Congress Center Basel, MCH Messe Schweiz (Basel) AG, CH-4005 Basel, Switzerland. Presentation Date & Speakers: Sep-30-2014, Florent Gros, Managing Director in Basel, Reinhard Ambros, Global Head.

Similar Private Companies By Industry

Company Name Region
Banque Heritage S.A. Europe
Soditic S.A. Europe
Sequoia International Investments Europe
Trinity Advisers SA Europe
Handinter Kappa AG Europe

Recent Private Companies Transactions

Type
Date
Target
Private Placement
April 9, 2015
Innocrin Pharmaceuticals Inc.
Private Placement
April 7, 2015
Nabriva Therapeutics AG
Private Placement
March 10, 2015
Aeglea Biotherapeutics, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Novartis Venture Fund, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.